大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/08/21 | 1,910 | 1,914 | 1,861 | 1,888 | -9 | -0.5% | 230,700 |
2015/08/20 | 1,851 | 1,916 | 1,851 | 1,897 | +36 | +1.9% | 131,400 |
2015/08/19 | 1,893 | 1,893 | 1,851 | 1,861 | -34 | -1.8% | 64,200 |
2015/08/18 | 1,916 | 1,935 | 1,881 | 1,895 | -15 | -0.8% | 102,900 |
2015/08/17 | 1,895 | 1,925 | 1,863 | 1,910 | +27 | +1.4% | 191,800 |
2015/08/14 | 1,838 | 1,894 | 1,825 | 1,883 | +45 | +2.4% | 167,800 |
2015/08/13 | 1,820 | 1,850 | 1,808 | 1,838 | -6 | -0.3% | 164,500 |
2015/08/12 | 1,866 | 1,888 | 1,832 | 1,844 | -46 | -2.4% | 168,000 |
2015/08/11 | 1,888 | 1,890 | 1,857 | 1,890 | +7 | +0.4% | 114,300 |
2015/08/10 | 1,870 | 1,887 | 1,855 | 1,883 | +21 | +1.1% | 69,900 |
2015/08/07 | 1,861 | 1,868 | 1,854 | 1,862 | -4 | -0.2% | 46,500 |
2015/08/06 | 1,869 | 1,891 | 1,865 | 1,866 | -28 | -1.5% | 65,200 |
2015/08/05 | 1,866 | 1,899 | 1,844 | 1,894 | +36 | +1.9% | 79,600 |
2015/08/04 | 1,882 | 1,882 | 1,843 | 1,858 | -26 | -1.4% | 111,200 |
2015/08/03 | 1,908 | 1,925 | 1,881 | 1,884 | -32 | -1.7% | 55,100 |
2015/07/31 | 1,895 | 1,918 | 1,856 | 1,916 | +57 | +3.1% | 109,000 |
2015/07/30 | 1,900 | 1,901 | 1,852 | 1,859 | -36 | -1.9% | 109,200 |
2015/07/29 | 1,925 | 1,932 | 1,885 | 1,895 | -45 | -2.3% | 74,000 |
2015/07/28 | 1,890 | 1,945 | 1,871 | 1,940 | +41 | +2.2% | 111,200 |
2015/07/27 | 1,925 | 1,925 | 1,890 | 1,899 | -26 | -1.4% | 68,600 |
2015/07/24 | 1,929 | 1,945 | 1,919 | 1,925 | -20 | -1% | 65,800 |
2015/07/23 | 1,920 | 1,945 | 1,911 | 1,945 | +31 | +1.6% | 165,400 |
2015/07/22 | 1,908 | 1,919 | 1,885 | 1,914 | +5 | +0.3% | 109,400 |
2015/07/21 | 1,895 | 1,919 | 1,886 | 1,909 | +40 | +2.1% | 145,000 |
2015/07/17 | 1,885 | 1,885 | 1,850 | 1,869 | +14 | +0.8% | 74,200 |
2015/07/16 | 1,907 | 1,907 | 1,848 | 1,855 | -42 | -2.2% | 103,100 |
2015/07/15 | 1,905 | 1,914 | 1,892 | 1,897 | -7 | -0.4% | 53,700 |
2015/07/14 | 1,910 | 1,923 | 1,891 | 1,904 | +9 | +0.5% | 79,900 |
2015/07/13 | 1,861 | 1,910 | 1,853 | 1,895 | +35 | +1.9% | 141,200 |
2015/07/10 | 1,890 | 1,916 | 1,851 | 1,860 | -27 | -1.4% | 167,200 |
2015/07/09 | 1,812 | 1,890 | 1,805 | 1,887 | +37 | +2% | 277,000 |
2015/07/08 | 1,836 | 1,868 | 1,835 | 1,850 | +8 | +0.4% | 281,500 |
2015/07/07 | 1,817 | 1,847 | 1,791 | 1,842 | +25 | +1.4% | 131,200 |
2015/07/06 | 1,801 | 1,826 | 1,796 | 1,817 | +2 | +0.1% | 82,000 |
2015/07/03 | 1,808 | 1,820 | 1,797 | 1,815 | +7 | +0.4% | 79,100 |
2015/07/02 | 1,830 | 1,831 | 1,801 | 1,808 | -26 | -1.4% | 96,100 |
2015/07/01 | 1,761 | 1,846 | 1,760 | 1,834 | +48 | +2.7% | 218,300 |
2015/06/30 | 1,751 | 1,786 | 1,751 | 1,786 | +26 | +1.5% | 164,000 |
2015/06/29 | 1,774 | 1,775 | 1,751 | 1,760 | -40 | -2.2% | 114,400 |
2015/06/26 | 1,800 | 1,808 | 1,785 | 1,800 | +2 | +0.1% | 121,100 |
2015/06/25 | 1,805 | 1,819 | 1,797 | 1,798 | -22 | -1.2% | 87,400 |
2015/06/24 | 1,813 | 1,833 | 1,804 | 1,820 | +3 | +0.2% | 84,700 |
2015/06/23 | 1,800 | 1,820 | 1,800 | 1,817 | +23 | +1.3% | 71,400 |
2015/06/22 | 1,771 | 1,804 | 1,771 | 1,794 | -6 | -0.3% | 93,000 |
2015/06/19 | 1,816 | 1,819 | 1,785 | 1,800 | -11 | -0.6% | 106,100 |
2015/06/18 | 1,815 | 1,830 | 1,790 | 1,811 | -24 | -1.3% | 186,100 |
2015/06/17 | 1,830 | 1,838 | 1,813 | 1,835 | -4 | -0.2% | 134,300 |
2015/06/16 | 1,858 | 1,888 | 1,827 | 1,839 | -21 | -1.1% | 186,200 |
2015/06/15 | 1,820 | 1,861 | 1,812 | 1,860 | +44 | +2.4% | 214,200 |
2015/06/12 | 1,832 | 1,837 | 1,805 | 1,816 | -8 | -0.4% | 112,900 |
2401~
2450
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
CANBAS | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム